IDNA holdings: all 55 positions
IDNA held 55 positions as of Oct 13, 2026. Moderna is the largest at 13.10%; the top 10 are 49.4% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | Moderna | MRNA | 13.10% |
| 2 | Twist Bioscience | TWST | 6.28% |
| 3 | Iovance Biotherapeutics Inc | IOVA | 5.07% |
| 4 | Genmab | GMAB | 4.31% |
| 5 | Revolution Medicines | RVMD | 3.63% |
| 6 | Takeda Pharmaceutical | 3.51% | |
| 7 | Regeneron Pharmaceuticals | REGN | 3.41% |
| 8 | Bayer AG | BAYN | 3.40% |
| 9 | Merck & Co Inc | MRK | 3.38% |
| 10 | Immunitybio | IBRX | 3.32% |
| 11 | Caris Life Sciences | CAI | 3.26% |
| 12 | Exelixis Inc | EXEL | 3.24% |
| 13 | Vertex Pharmaceuticals | VRTX | 3.12% |
| 14 | Incyte Corp | INCY | 3.05% |
| 15 | Roche Ps Par AG | ROP | 3.02% |
| 16 | Biontech SE ADR | BNTX | 2.91% |
| 17 | Abcellera Biologics | ABCL | 2.67% |
| 18 | Glaxosmithkline | GSK | 2.57% |
| 19 | Ideaya Biosciences | IDYA | 2.57% |
| 20 | Sanofi SA | SAN | 2.53% |
| 21 | Ipsen SA | IPN | 2.52% |
| 22 | Novavax | NVAX | 1.81% |
| 23 | Arcus Biosciences | RCUS | 1.70% |
| 24 | ONO Pharmaceutical | 1.46% | |
| 25 | Crispr Therapeutics AG | CRSP | 1.29% |
| 26 | VIR Biotechnology | VIR | 1.28% |
| 27 | Nuvation Bio Class A | NUVB | 1.05% |
| 28 | Janux Therapeutics | JANX | 0.89% |
| 29 | Personalis | PSNL | 0.88% |
| 30 | Kura Oncology | KURA | 0.76% |
| 31 | Rigel Pharmaceuticals | RIGL | 0.76% |
| 32 | Sunshine Lake Pharma Ltd Class H | 0.74% | |
| 33 | Genfleet Therapeutics (shanghai) I | 0.60% | |
| 34 | Verastem Inc | VSTM | 0.55% |
| 35 | Alvotech SA | ALVO | 0.55% |
| 36 | Corvus Pharmaceuticals | CRVS | 0.54% |
| 37 | Pacific Biosciences of California | PACB | 0.53% |
| 38 | Ginkgo Bioworks Holdings Class A | DNA | 0.49% |
| 39 | Xencor | XNCR | 0.48% |
| 40 | Intellia Therapeutics | NTLA | 0.45% |
| 41 | Valneva | VLA | 0.41% |
| 42 | Shanghai Henlius Biotech H | 0.39% | |
| 43 | Cytomx Therapeutics | CTMX | 0.36% |
| 44 | Design Therapeutics | DSGN | 0.33% |
| 45 | Ocugen | OCGN | 0.27% |
| 46 | Abclon Inc | 0.25% | |
| 47 | Prime Medicine | PRME | 0.09% |
| 48 | Arcellx Inc Cvr | 0.00% | |
| 49 | Hkd/Usd | HKD | 0.00% |
| 50 | Dkk/Usd | DKK | 0.00% |
| 51 | Dkk/Usd | DKK | 0.00% |
| 52 | OMNIAB INC $12.50 VESTING Prvt | 0.00% | |
| 53 | OMNIAB INC $15.00 VESTING Prvt | 0.00% | |
| 54 | E-Mini Health Care Sector Dec 26 | 0.00% | |
| 55 | Krw/Usd | KRW | 0.00% |
| BLK Csh Fnd Treasury Sl Agency | 0.18% | ||
| JPY Cash | 0.07% | ||
| EUR Cash | 0.02% | ||
| Cash Collateral Usd Hbcft | 0.02% | ||
| CHF Cash | 0.01% | ||
| GBP Cash | 0.00% | ||
| TWD Cash | 0.00% | ||
| KRW Cash | 0.00% | ||
| DKK Cash | 0.00% | ||
| HKD Cash | −0.02% | ||
| USD Cash | −0.05% | ||
| Cash and other net assets | −0.01% |
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of IDNA, data as of Oct 13, 2026. https://etfiq.com/funds/idna/holdings/
ETFIQ. (Oct 13, 2026). Holdings of IDNA. Retrieved from https://etfiq.com/funds/idna/holdings/
[Holdings of IDNA (ETFIQ, Oct 13, 2026)](https://etfiq.com/funds/idna/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.